Drug Database
Back to search

Iceland· IS-853626

Persantin

A dipyridamole product containing dipyridamolum inn, registered in Iceland by Glenwood GmbH Pharmazeutische Erzeugnisse. The same ATC class is registered in 11 of our 19 countries.

ATC B01AC07

Checked against Icelandic Medicines Agency (Iceland) on

Informational only — not a medical device.

SOURCE REGISTER · ISIcelandic Medicines Agency (Iceland)normalisedPersantinATCB01AC07REGISTER NO.IS-853626PACKS LISTED2CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about dipyridamolum innAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Dipyridamole is registered in 11 of 19 countries.

Countries holding a registration under ATC B01AC07 (dipyridamole), each read from that country’s own register.

  • This record: Iceland, from Icelandic Medicines Agency (Iceland)
  • 6 of them publish a price we can compare per daily dose
Search dipyridamole products by name

Dipyridamole · ATC B01AC07

11 / 19 countries

  • Belgiumprice
  • Canada
  • Denmark
  • Finlandprice
  • Franceprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Icelandic Medicines Agency (Iceland)
Active substance
Dipyridamolum INN
Manufacturer
Glenwood GmbH Pharmazeutische Erzeugnisse
Country
Iceland (IS)
ATC code
B01AC07
ATC class
Dipyridamole
Defined daily dose
0.4 g, O
Reimbursed
Not published by this register
Source register
Icelandic Medicines Agency (Iceland)
Last checked
September 29, 2026

Packs & prices · 2

2 priced
  • ean
    551043
    100 stk x1 þpakki
    ISK 5051
  • ean
    984072
    50 stk x1 pakki
    ISK 5309

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

352 interactions on record for dipyridamole.

Graded by severity as the source publishes them — 47 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check dipyridamole against other medicinesHow interaction checks work

Dipyridamole · interactions on record

352 records

  • 47 severe
  • 93 moderate
  • 5 minor
  • 207 info

Most severe, free to view

  • DalteparinB01AB04severe
  • EnoxaparinB01AB05severe
  • DanaparoidB01AB09severe
  • TinzaparinB01AB10severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Dipyridamole in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All dipyridamole products

Authorised across Europe · EMA

The same active substance is authorised in 17 EEA countries. Names it is sold under:

  • Austria · Persantin
  • Bulgaria · Антистенокардин, Биокардин
  • Cyprus · Perazodin, Persantin
  • Denmark · Dipyridamol Alternova, Dipyridamol Strides
  • Spain · Persantin
  • Finland · Persantin
  • France · Persantine
  • United Kingdom (Northern Ireland) · Attia, Dipyridamole Dr. Reddy’s
  • Greece · Persantin
  • Croatia · Persantin
  • Ireland · Pyranistole
  • Italy · Corosan, Persantin
  • Malta · Perazodin
  • Netherlands · Dipyridamol Glenmark, Dipyridamol Sandoz
  • Norway · Aponova, Dipyridamol Glenmark
  • Portugal · Dipiridamol Labesfal, Persantin
  • Sweden · Dipyridamol Alternova, Pyranistole

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/3649183c-1b95-4d8e-b167-9eedcfb83070
GET /v1/drugs/3649183c-1b95-4d8e-b167-9eedcfb83070?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Húðuð tafla",
  "source": "lyfjastofnun",
  "atc_raw": "B01AC07",
  "marketed": true,
  "strength": "100 mg",
  "ma_number": "853626",
  "substance": "Dipyridamolum INN",
  "other_info": null,
  "legal_status": "(R) Lyfseðilsskylt",
  "ma_issued_serial": "31253"
}
API referenceMCP serverPlans

See everything about dipyridamole.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console